logo-loader
Neurotrope

Neurotrope anticipates data from its drug to treat Alzheimer's summer 2019

Neurotrope Inc (NASDAQ:NTRP) CEO Dr. Charles Ryan sat down with Proactive Investors at the BIO CEO & Investor Conference in New York.

Ryan says the company anticipates data from its drug to treat Alzheimer's summer 2019.

Quick facts: Neurotrope

Price: $5.67

Market: NASDAQ
Market Cap: $73.83 m
Follow

Watch

e-Therapeutics’ Barlow hails deals with Novo Nordisk and ‘top five pharma...

Ray Barlow, chief executive of e-Therapeutics (LON:ETX), talks to Proactive’s Andrew Scott about the company’s unique approach to drug discovery, which uses computational techniques to find potential breakthrough new treatments. He also provided some insight into recent tie-ups with Denmark’s...

4 days, 2 hours ago

2 min read

;